FORT SHERIDAN ADVISORS LLC – Eli Lilly and Company Transaction History
FORT SHERIDAN ADVISORS LLC portfolio value:
$678,000
portfolio value
FORT SHERIDAN ADVISORS LLC quarter portfolio value change:
-0.27%
quarter
Eli Lilly and Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -8.75% | -201 shares | -67K | $323.35 | 2.09K |
| Q2 2022 | share | Increase | +8.14% | 173 shares | 136K | $324.23 | 2.29K |
| Q1 2022 | share | Increase | +1.58% | 33 shares | 31K | $286.37 | 2.12K |
| Q4 2021 | share | Increase | +17.40% | 310 shares | 166K | $277.25 | 2.09K |
| Q3 2021 | share | Decrease | -1.49% | -27 shares | -3K | $230.3 | 1.78K |
| Q2 2021 | share | Decrease | -2.32% | -43 shares | 69K | $228.04 | 1.80K |
| Q1 2021 | share | Increase | +8.81% | 150 shares | 59K | $184.81 | 1.85K |
| Q4 2020 | share | Decrease | -18.99% | -399 shares | -24K | $166.32 | 1.70K |
| Q3 2020 | share | Increase | 0.00% | 2.10K shares | 311K | $145.05 | 2.10K |